IBB
NASDAQ
$189.31
ISHARES BIOTECHNOLOGY ETF (IBB)
Sector:
Healthcare
Net assets
$9.10B
Inception date
February 5, 2001
Expense ratio
0.44%
Sharpe Ratio
1.78
Price Chart
Valuation
Net assets$9.10B
Forward P/E18.91
P/S6.91
P/B5.48
Profitability
Profit Margin2.3%
Operating Margin-211.1%
Financial Health
Debt-to-Equity75.8%
Growth & Risk
EPS 5Y CAGR+16.11%
Revenue 5Y CAGR+27.43%
FCF 5Y CAGR+16.32%
Dividends 5Y CAGR+0.10%
Beta (5Y)0.78
Sharpe Ratio1.78